These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7727 related articles for article (PubMed ID: 2450880)

  • 21. Immediate early gene expression in dog thyrocytes in response to growth, proliferation, and differentiation stimuli.
    Deleu S; Pirson I; Clermont F; Nakamura T; Dumont JE; Maenhaut C
    J Cell Physiol; 1999 Nov; 181(2):342-54. PubMed ID: 10497313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
    Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
    Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dexamethasone inhibits feedback regulation of the mitogenic activity of tumor necrosis factor, interleukin-1, and epidermal growth factor in human fibroblasts.
    Kohase M; Henriksen-Destefano D; Sehgal PB; Vilcek J
    J Cell Physiol; 1987 Aug; 132(2):271-8. PubMed ID: 3040777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor necrosis factor-alpha affects LTR-controlled oncogene expression in transformed mouse fibroblasts at the post-transcriptional level.
    Seliger B; Stark G; Pfizenmaier K
    J Immunol; 1988 Sep; 141(6):2138-44. PubMed ID: 2844896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of epidermal growth factor and fetal calf serum in human endometrial carcinoma RL95-2 cells.
    Sallot M; Lascombe I; Bermont L; Jouvenot M
    Anticancer Res; 1997; 17(5A):3499-504. PubMed ID: 9413194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced expression of c-erbB2 gene product in human mammary carcinoma SK-BR-3 cells treated with interferon-gamma and tumor necrosis factor-alpha.
    Kumar R; Mendelsohn J
    Anticancer Res; 1994; 14(3A):1001-8. PubMed ID: 7915505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-IgM-induced growth inhibition and apoptosis are independent of ornithine decarboxylase in Ramos cells.
    Lin CK; Zou HY; Kaptein JS; Yen CF; Kalunta CI; Nguyen TT; Park E; Lad PM
    Exp Cell Res; 1997 Nov; 237(1):231-41. PubMed ID: 9417887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative modes of c-myc regulation in growth factor-stimulated and differentiating cells.
    Nepveu A; Levine RA; Campisi J; Greenberg ME; Ziff EB; Marcu KB
    Oncogene; 1987; 1(3):243-50. PubMed ID: 2455262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
    Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
    Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor-alpha stimulates cell proliferation in adipose tissue-derived stromal-vascular cell culture: promotion of adipose tissue expansion by paracrine growth factors.
    Kras KM; Hausman DB; Martin RJ
    Obes Res; 2000 Mar; 8(2):186-93. PubMed ID: 10757205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth factors and proto-oncogenes in early mouse embryogenesis and tumorigenesis.
    Pavelić K; Pecina Slaus N; Spaventi R
    Int J Dev Biol; 1991 Sep; 35(3):209-14. PubMed ID: 1814404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasminogen activator inhibitor type-2 is a major protein induced in human fibroblasts and SK-MEL-109 melanoma cells by tumor necrosis factor.
    Pytel BA; Peppel K; Baglioni C
    J Cell Physiol; 1990 Sep; 144(3):416-22. PubMed ID: 2391377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of epidermal growth factor on the expression of protooncogenes c-myc and c-Ha-ras in short-term primary hepatocyte culture.
    Kost DP; Michalopoulos GK
    J Cell Physiol; 1990 Jul; 144(1):122-7. PubMed ID: 2195043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor necrosis factor as an autocrine growth factor for neuroblastoma.
    Goillot E; Combaret V; Ladenstein R; Baubet D; Blay JY; Philip T; Favrot MC
    Cancer Res; 1992 Jun; 52(11):3194-200. PubMed ID: 1317260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-induction of defense against tumor necrosis factor cytotoxicity in tumor cells and normal cells.
    Watanabe N; Neda H; Yamauchi N; Maeda M; Sone H; Kuriyama H; Niitsu Y
    Immunopharmacol Immunotoxicol; 1988; 10(4):479-99. PubMed ID: 3246539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor necrosis factor-alpha inhibits 1,25-dihydroxyvitamin D3-stimulated bone Gla protein synthesis in rat osteosarcoma cells (ROS 17/2.8) by a pretranslational mechanism.
    Nanes MS; Rubin J; Titus L; Hendy GN; Catherwood B
    Endocrinology; 1991 May; 128(5):2577-82. PubMed ID: 2019266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissociation of thymidine incorporation and transferrin receptor expression from cell growth and c-myc accumulation in alpha-interferon-treated cells.
    Meadows LM; George DJ; Kaufman RE
    J Biol Response Mod; 1990 Apr; 9(2):212-20. PubMed ID: 2187953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mitogenic response of AML blasts to tumor necrosis factor-alpha requires functional c-jun/AP-1.
    Brach MA; Herrmann F
    Leukemia; 1993 Aug; 7 Suppl 2():S22-6. PubMed ID: 8361227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor-alpha increases hepatic DNA and RNA and hepatocyte mitosis.
    Beyer HS; Stanley M
    Biochem Int; 1990 Nov; 22(3):405-10. PubMed ID: 1706180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of growth stimulatory factors on mitogenicity and c-myc expression in poorly differentiated and well differentiated human colon carcinoma cells.
    Mulder KM; Brattain MG
    Mol Endocrinol; 1989 Aug; 3(8):1215-22. PubMed ID: 2674694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 387.